ExodusPoint Capital Management, LP - Nov 10, 2025 SCHEDULE 13G Report for Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share (KROS)

Filing Manager
ExodusPoint Capital Management, LP
Reporting Manager
ExodusPoint Capital Management, LP
Security
Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
KROS
Shares outstanding
30.3M shares
Disclosed Ownership
1.91M shares
Ownership
6.3%
Form type
SCHEDULE 13G
Date filed
11/18/2025, 04:07 PM
Date of event
Nov 10, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ExodusPoint Capital Management, LP 6.3% 1.91M 0 1.91M /s/ Timothy Cruise Timothy Cruise, Authorized Signatory
ExodusPoint Capital Partners GP, LLC 6.3% 1.91M 0 1.91M /s/ Timothy Cruise Timothy Cruise, Authorized Signatory
Michael Gelband 6.3% 1.91M 0 1.91M /s/ Michael Gelband Michael Gelband